Download FREE Report Sample
Download Free sampleMany pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.
Although several types of oligonucleotide therapies exist, five of them are compared here, including the ones targeting nucleic acids (such as mRNA) or proteins, as well as others intended for stimulation of the immune system. DDS is generally used with oligonucleotide therapy, as it is difficult for these molecules to penetrate cell membrane when administered on their own.
Oligonucleotide Therapeutics Market contains market size and forecasts of Oligonucleotide Therapeutics in Global, including the following market information:
Global Oligonucleotide Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Oligonucleotide Therapeutics market was valued at 3784.6 million in 2021 and is projected to reach US$ 10680 million by 2028, at a CAGR of 16.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antisense Oligonucleotide Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oligonucleotide Therapeutics include Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Bausch & Lomb, Alnylam Pharmaceuticals, Dynavax Technologies, Kastle therapeutics and Akcea Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oligonucleotide Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oligonucleotide Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Oligonucleotide Therapeutics Market Segment Percentages, by Type, 2021 (%)
Antisense Oligonucleotide
Aptamer
Other
Global Oligonucleotide Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Oligonucleotide Therapeutics Market Segment Percentages, by Application, 2021 (%)
Neuromuscular Diseases
ATTR
Hepatic VOD
Other
Global Oligonucleotide Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Oligonucleotide Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oligonucleotide Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Oligonucleotide Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Sarepta Therapeutics
Jazz Pharmaceuticals
Bausch & Lomb
Alnylam Pharmaceuticals
Dynavax Technologies
Kastle therapeutics
Akcea Therapeutics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
